BRIEF-Cascadian Therapeutics to sell shares of Series D convertible preferred stock

* Intends to sell shares of Series D convertible preferred

stock having an aggregate value of up to $13.8 million

Source text for Eikon:

Further company coverage:

(Bengaluru Newsroom: +1-646-223-8780)

Read more